| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |